Olon spa
  • Home
  • Company
    • About Us
    • History
    • Ethics
    • Facilities
  • Generics
    • API
    • Dossier
    • Quality / RA
  • CDMO/CMO
    • Who is Olon
    • Chemistry
    • Fermentation
  • NEWS
  • Careers
  • Contact

R&D

Home / GLOBAL LEADERSHIP IN ACTIVE PHARMACEUTICAL INGREDIENTS / R&D

1–10 di 48 risultati

  • Bronchodilator (COPD) , R&D

    ALBUTEROL (SALBUTAMOL) SULFATE

    CAS No: 51022-70-9

    CAS No: 51022-70-9

    DETAIL
  • Antineoplastic (Soft Tissue Sarcoma - STS) , R&D

    ALDOXORUBICIN HYDROCHLORIDE

    CAS No: 480998-12-7

    CAS No: 480998-12-7

    DETAIL
  • Antineoplastic (Prostate) , R&D

    APALUTAMIDE

    CAS No: 956104-40-8

    CAS No: 956104-40-8

    DETAIL
  • Antineoplastic (Leukemia) , R&D

    AZACITIDINE

    CAS No: 320-67-2

    CAS No: 320-67-2

    DETAIL
  • Antihypertensive , R&D

    BARNIDIPINE HYDROCHLORIDE

    DMF
    GMP

    CAS No: 104757-53-1

    DMF
    GMP

    CAS No: 104757-53-1

    DETAIL
  • Antineoplastic (Skin) , R&D

    BEXAROTENE

    CAS No: 153559-49-0

    CAS No: 153559-49-0

    DETAIL
  • Antipsychotic , R&D

    BLONANSERIN

    DMF
    GMP

    CAS No: 132810-10-7

    DMF
    GMP

    CAS No: 132810-10-7

    DETAIL
  • Antithrombotic , R&D

    CANGRELOR TETRASODIUM

    DMF

    CAS No: 163706-36-3

    DMF

    CAS No: 163706-36-3

    DETAIL
  • Atopic dermatitis , R&D

    CRISABOROLE

    DMF

    CAS No: 906673-24-3

    DMF

    CAS No: 906673-24-3

    DETAIL
  • Antispastic , R&D

    DANTROLENE SODIUM

    CAS No: 14663-23-1

    CAS No: 14663-23-1

    DETAIL
  • 1
  • 2
  • 3
  • 4
  • 5
  • →

Olon S.p.A.
Società con Socio unico
Strada Rivoltana km 6/7
20090 Rodano (Milano) | ITALY
Phone: +39 02 95 231
E-mail: info@olonspa.it
P.IVA 08101100157
Capitale Sociale € 40.000.000 i.v.
R.E.A. Milano n. 1201640

Newsletter
Follow Us

  • Cookie Policy
  • Privacy Policy
  • GDPR UE 2016/679
Powered by Work in Progress
X
By continuing to use our website, you consent to the usage of cookies as described in our Cookie Policy.OkMore information